🔴 Royalty Pharma is trading 6% down in after-hours trading with no clear company-specific catalyst

Royalty Pharma is trading at $60.15 (-5.96%) after no clear company-specific announcement was identified for September 4, 2026.

• Broader markets weakened, with the S&P 500 down 0.48% and Nasdaq down 0.65%.
• Strong August jobs data lifted rate-hike concerns and Treasury yields.
• Latest located company updates were the August 5 earnings release and August 12 Zealand Pharma funding agreement, rather than fresh after-hours news; the unusually large decline remains unexplained.